Greenovation Biotech - Articles and news items

Greenovation to start Phase I clinical trial for moss-aGal

Industry news / 16 September 2015 / Victoria White

Moss-aGal, a recombinant form of human alpha galactosidase, is the world´s first moss-produced drug candidate…

 

The deadline for submissions to the EPR Awards is 9 June 2017! Entry is FREE, so don't delay...
+